FDAs Orphan Drug Workshop Featured in Wall Street Journal – Push To Cure Rare Diseases
March 10, 2010 by Chris Hempel
Filed under Featured Stories
Below is a story that ran in today’s Wall Street Journal (Page A 3) on the FDA workshop I attended a few week ago at the Keck Graduate Institute in Claremont, CA. We filed an orphan drug application for Cyclodextrin for the treatment of Niemann Pick Type C disease, an ultra rare cholesterol disease that […]
